The synthetic retinoid RO 13-6307 induces neuroblastoma differentiationin vitro and inhibits neuroblastoma tumour growthin vivo
Open Access
- 15 January 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 104 (4), 418-424
- https://doi.org/10.1002/ijc.10954
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivoMedical and Pediatric Oncology, 2001
- A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapyBritish Journal of Cancer, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Apoptosis of N-Type Neuroblastoma Cells After Differentiation With 9-cis-Retinoic Acid and Subsequent WashoutJNCI Journal of the National Cancer Institute, 1997
- Retinoic acid and retinoic acid receptors in developmentMolecular Neurobiology, 1995
- Preparation of cell nuclei from fresh tissues for high‐quality DNA flow cytometryCytometry, 1993
- Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids.Proceedings of the National Academy of Sciences, 1993
- A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects.Proceedings of the National Academy of Sciences, 1992
- 13‐cis‐retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cancer study groupMedical and Pediatric Oncology, 1992
- A Novel Chromosome Abnormality in Human Neuroblastoma and Antifolate-Resistant Chinese Hamster Cell Lines in Culture 1 2JNCI Journal of the National Cancer Institute, 1976